Table 1 The clinical data and pathological characteristics of 85 CIN cases

Ages

20–64

40.4 ± 11.1

 Pre-menopause

77

90.60%

 Post-menopause

8

9.40%

HR-HPV positive genotype

72

84.70%

 HPV16

9

10.60%

 HPV18

8

9.40%

 ^aOther 12 HR-HPV types

45

52.90%

 HPV16 + 18

2

2.40%

 HPV16 + Other 12 types

6

7.10%

 HPV16 + 18 + Other 12 types

2

2.40%

HR-HPV negative genotype

13

15.30%

P16

 Positive

48

56.50%

 Negative

37

43.50%

Ki67

 High expression

45

52.90%

 Low expression

40

47.10%

CIN

 CIN1

29

34.10%

 CIN2

31

36.50%

 CIN3

25

29.40%

Grouping

 Control

49

57.60%

 Test

36

42.40%